Where Patient Enrollment is Booming "Our data shows that more Americans are choosing medical marijuana for therapeutic purposes, especially ...

Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its potential genetic disorder drug KRRO-110. Shares rose 17.6% to $29 in premarket trading. The stock is ...